Chimeric peptide EP45 as a dual agonist at GLP-1 and NPY2R receptors

We report the design and target validation of chimeric peptide EP45, a novel 45 amino acid monomeric dual agonist peptide that contains amino acid sequence motifs present within the blood glucose-lowering agent exendin-4 (Ex-4) and the appetite-suppressing agent PYY(3–36). In a new high-throughput F...

Descripción completa

Detalles Bibliográficos
Autores principales: Chepurny, Oleg G., Bonaccorso, Ron L., Leech, Colin A., Wöllert, Torsten, Langford, George M., Schwede, Frank, Roth, Christian L., Doyle, Robert P., Holz, George G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830615/
https://www.ncbi.nlm.nih.gov/pubmed/29491394
http://dx.doi.org/10.1038/s41598-018-22106-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830615/
https://www.ncbi.nlm.nih.gov/pubmed/29491394
http://dx.doi.org/10.1038/s41598-018-22106-1

Ejemplares similares